Stock News
Pyxis Oncology, Inc. (PYXS) Discusses MICVO Monotherapy Phase I Clinical Data in Head and Neck Squamous Cell Carcinoma Transcript
Follow Pyxis Oncology, Inc. (PYXS) Discusses MICVO Monotherapy Phase I Clinical Data in Head and Neck Squamous Cell Carcinoma September 9, 2026 7:30 AM EDT Company Participants Thomas Civik – CEO & ChairmanMarsha Crochiere – […]
